Photo taken from Nucleai/LinkedIn
May 25, 2024, 05:35
Nucleai – Explore the future of AI spatial biomarkers and precision oncology with at ASCO24
Oscar Puig, VP Translational Medicine and Diagnostics at , shared a post by
“Artificial intelligence is changing the way pathology images are analyzed and scored. There is so much information in those images about the tumor morphology, tumor microenvironment, cell composition, densities and distances. spatial biology digital pathology is improving how patients are treated. Learn more at ASCO24. See you there!!!!”
Quoting ‘s post:
“ASCO24 kicks off next week! Don’t miss the chance to meet our commercial and strategic team and explore the future of AI spatial biomarkers and precision oncology with us. ”
Additional details.
Source: Oscar Puig/LinkedIn and
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 09:56
Aug 8, 2025, 09:32
Aug 8, 2025, 09:23
Aug 8, 2025, 09:08